Shares of JAN (NYSE:JAN – Get Free Report) shot up 4.4% on Tuesday . The company traded as high as $31.00 and last traded at $31.0560. Approximately 848,364 shares changed hands during trading, a decline of 40% from the average daily volume of 1,407,272 shares. The stock had previously closed at $29.75.
JAN News Summary
Here are the key news stories impacting JAN this week:
- Neutral Sentiment: No new JAN announcement: The latest news set contains no updates on JanOne’s operations, clinical programs, financing, contracts, or regulatory developments, suggesting the move may be driven by broader market activity, technical trading, or investor positioning.
- Positive Sentiment: Revenue growth remains supportive: In its most recent earnings report, JAN posted quarterly revenue of $216.46 million, exceeding estimates of $203.32 million and rising 45.4% year over year.
- Negative Sentiment: Earnings miss remains a risk: The company reported quarterly EPS of $0.05, below the $0.23 analyst consensus. Investors may also be monitoring whether JanOne can achieve its fiscal 2026 EPS guidance of $0.95–$0.98.
Wall Street Analyst Weigh In
A number of research firms have recently commented on JAN. Cantor Fitzgerald increased their price target on shares of JAN from $30.00 to $34.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Wall Street Zen upgraded shares of JAN from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Raymond James Financial assumed coverage on shares of JAN in a research note on Tuesday, June 16th. They set a “strong-buy” rating and a $34.00 target price for the company. Wells Fargo & Company increased their price objective on shares of JAN from $33.00 to $35.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Weiss Ratings began coverage on shares of JAN in a report on Thursday, August 6th. They set a “hold (c-)” rating for the company. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $31.23.
JAN Stock Performance
The firm’s 50 day simple moving average is $29.96.
JAN (NYSE:JAN – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The business had revenue of $216.46 million during the quarter, compared to analyst estimates of $203.32 million. The company’s revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, analysts forecast that JAN will post 0.97 earnings per share for the current year.
JAN Announces Dividend
The firm also recently declared a monthly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Friday, September 11th will be issued a $0.0475 dividend. The ex-dividend date of this dividend is Friday, September 11th. This represents a c) dividend on an annualized basis and a yield of 1.8%.
Institutional Investors Weigh In On JAN
Several institutional investors and hedge funds have recently modified their holdings of the stock. Greenland Capital Management LP bought a new position in shares of JAN during the second quarter worth $575,000. Readystate Asset Management LP purchased a new stake in JAN in the 2nd quarter worth $1,724,000. Finally, Wellington Management Group LLP purchased a new stake in JAN in the 2nd quarter worth $8,739,000. Institutional investors own 6.27% of the company’s stock.
About JAN
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Featured Articles
- Five stocks we like better than JAN
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
